Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person small molecule inhibitors of RIPK1, RIPK3 [cytosol]

Class:Id	DefinedSet:9694028
_displayName	small molecule inhibitors of RIPK1, RIPK3 [cytosol]
_timestamp	2020-07-08 15:27:47
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:9694033] Shamovsky, Veronica, 2020-07-08
disease	[Disease:9677533] inflammation
hasMember	[ChemicalDrug:9669717] ponatinib [cytosol] [ChemicalDrug:9657029] sorafenib [cytosol] [ChemicalDrug:9616920] pazopanib [cytosol]
modified	[InstanceEdit:9694039] Shamovsky, Veronica, 2020-07-08
name	small molecule inhibitors of RIPK1, RIPK3 sorafenib, ponatinib
species	[Species:48887] Homo sapiens
stableIdentifier	[StableIdentifier:9694037] R-HSA-9694028.1
(hasComponent)	[Complex:9693943] RIPK1:RIPK3:sorafenib, ponatinib, pazopanib [cytosol] [Homo sapiens]
(input)	[Reaction:9693978] Small molecule inhibitor binds RIPK1, RIPK3 [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by small molecule inhibitors of RIPK1, RIPK3 [cytosol] (9694028)